162 related articles for article (PubMed ID: 37773558)
1. Impact of dexmedetomidine on electrophysiological properties and arrhythmia inducibility in adult patients referred for reentrant supraventricular tachycardia ablation.
Bernardini A; Paoletti Perini A; Padeletti M; Signorini U; Ciliberti D; Poli C; Milli M; Giomi A
J Interv Card Electrophysiol; 2024 Mar; 67(2):371-378. PubMed ID: 37773558
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic and electrophysiologic effects of dexmedetomidine on children.
Ergul Y; Unsal S; Ozyilmaz I; Ozturk E; Carus H; Guzeltas A
Pacing Clin Electrophysiol; 2015 Jun; 38(6):682-7. PubMed ID: 25753681
[TBL] [Abstract][Full Text] [Related]
3. Choosing the anesthetic and sedative drugs for supraventricular tachycardia ablations: A focused review.
Vladinov G; Fermin L; Longini R; Ramos Y; Maratea E
Pacing Clin Electrophysiol; 2018 Nov; 41(11):1555-1563. PubMed ID: 30251322
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Sedation for Paroxysmal Supraventricular Tachycardia Ablation Is Not Associated With Alteration of Arrhythmia Inducibility.
Slupe AM; Minnier J; Raitt MH; Zarraga IGE; MacMurdy KS; Jessel PM
Anesth Analg; 2019 Dec; 129(6):1529-1535. PubMed ID: 31743172
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological features differentiating the atypical atrioventricular node-dependent long RP supraventricular tachycardias.
Ho RT; Frisch DR; Pavri BB; Levi SA; Greenspon AJ
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):597-605. PubMed ID: 23629734
[TBL] [Abstract][Full Text] [Related]
6. The effects of dexmedetomidine on cardiac electrophysiology in children.
Hammer GB; Drover DR; Cao H; Jackson E; Williams GD; Ramamoorthy C; Van Hare GF; Niksch A; Dubin AM
Anesth Analg; 2008 Jan; 106(1):79-83, table of contents. PubMed ID: 18165557
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine use in patients undergoing electrophysiological study for supraventricular tachyarrhythmias.
Tirotta CF; Nguyen T; Fishberger S; Velis E; Olen M; Lam L; Madril DR; Hughes J; Lagueruela RG
Paediatr Anaesth; 2017 Jan; 27(1):45-51. PubMed ID: 27779344
[TBL] [Abstract][Full Text] [Related]
8. Modification of human atrioventricular nodal function by selective atrioventricular nodal artery catheterization.
Wang PJ; Sosa-Suarez G; Friedman PL
Circulation; 1990 Sep; 82(3):817-29. PubMed ID: 2394004
[TBL] [Abstract][Full Text] [Related]
9. AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events.
Brembilla-Perrot B; Bénichou M; Brembilla A; Bozec E; Dorlet S; Sellal JM; Olivier A; Manenti V; Villemin T; Beurrier D; Moulin-Zinsch A; De Chillou C; Girerd N
Int J Cardiol; 2015 Nov; 199():84-9. PubMed ID: 26188825
[TBL] [Abstract][Full Text] [Related]
10. Intravenous flecainide acetate for supraventricular tachycardias.
Hellestrand KJ
Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
[TBL] [Abstract][Full Text] [Related]
11. The retrograde P-wave theory: explaining ST segment depression in supraventricular tachycardia by retrograde AV node conduction.
Rivera S; De La Paz Ricapito M; Conde D; Verdu MB; Roux JF; Paredes FA
Pacing Clin Electrophysiol; 2014 Sep; 37(9):1100-5. PubMed ID: 24697871
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiology Study for Complex Supraventricular Tachycardia in Congenital Heart Disease Patients With Single-Ventricle Physiology.
Chiu SN; Wang JK; Lu CW; Wu KL; Tseng WC; Wu MH
J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27799231
[TBL] [Abstract][Full Text] [Related]
13. Association between atrioventricular node reentrant tachycardia and inducible atrial flutter.
Kalbfleisch SJ; el-Atassi R; Calkins H; Langberg JJ; Morady F
J Am Coll Cardiol; 1993 Jul; 22(1):80-4. PubMed ID: 8509568
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
15. Slow pathway ablation in children with documented reentrant supraventricular tachycardia not inducible during invasive electrophysiologic study.
Emmel M; Brockmeier K; Sreeram N
Z Kardiol; 2005 Dec; 94(12):808-12. PubMed ID: 16382381
[TBL] [Abstract][Full Text] [Related]
16. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intravenous sotalol for suppressing inducibility of supraventricular tachycardias at rest and during isometric exercise.
Huikuri HV; Koistinen MJ; Takkunen JT
Am J Cardiol; 1992 Feb; 69(5):498-502. PubMed ID: 1736614
[TBL] [Abstract][Full Text] [Related]
19. A prospective placebo controlled randomized study of caffeine in patients with supraventricular tachycardia undergoing electrophysiologic testing.
Lemery R; Pecarskie A; Bernick J; Williams K; Wells GA
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):1-6. PubMed ID: 25081280
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Depresses Sinoatrial and Atrioventricular Nodal Function Without Any Change in Atrial Fibrillation Inducibility.
Sairaku A; Nakano Y; Suenari K; Tokuyama T; Kawazoe H; Matsumura H; Tomomori S; Amioka M; Kihara Y
J Cardiovasc Pharmacol; 2016 Dec; 68(6):473-478. PubMed ID: 27652911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
